Literature DB >> 6187372

Cell association and degradation of alpha 2-macroglobulin-trypsin complexes in hepatocytes and adipocytes.

J Gliemann, T R Larsen, L Sottrup-Jensen.   

Abstract

125I-Labelled alpha 2-macroglobulin-trypsin complex (125I-labelled alpha 2-macroglobulin X trypsin) was associated to isolated rat adipocytes and hepatocytes with a half-time of about 60 min at 37 degrees C. The association of 0.5 micrograms/ml 125I-labelled alpha 2-macroglobulin X trypsin was inhibited by unlabelled alpha 2-macroglobulin X trypsin with a half-inhibition constant of about 8 micrograms/ml (11 nM). 125I-Labelled alpha 2-macroglobulin became cell-associated to a smaller extent (10-40% of that of alpha 2-macroglobulin X trypsin) and the half-inhibition constant was about 35 micrograms/ml in adipocytes. The cell association of 125I-labelled alpha 2-macroglobulin X trypsin was markedly inhibited by dansylcadaverine, bacitracin, omission of Ca2+ from the medium or pretreatment of the cells with trypsin. After incubation for 180 min more than 60% of the cell-associated 125I-labelled alpha 2-macroglobulin X trypsin was not removed by treatment of the cells with trypsin-EDTA and represented probably internalized material. 125I-Labelled alpha 2-macroglobulin X trypsin was degraded to trichloroacetic acid-soluble fragments by suspensions of both cell types but only to a negligible extent by incubation media preincubated with these cells. The rate of degradation of 0.5 micrograms/ml 125I-labelled alpha 2-macroglobulin was approx. 40% of that of 125I-labelled alpha 2-macroglobulin X trypsin. Degradation of 125I-labelled alpha 2-macroglobulin X trypsin was abolished by a high concentration (0.5 mg/ml) of alpha 2-macroglobulin X trypsin. It is concluded that alpha 2-macroglobulin X trypsin by a specific and saturable mechanism is bound to, internalized and degraded by isolated rat adipocytes and hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187372     DOI: 10.1016/0304-4165(83)90096-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity.

Authors:  R E Morty; J D Lonsdale-Eccles; R Mentele; E A Auerswald; T H Coetzer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Further characterization of the platinum-reactive component of the alpha 2-macroglobulin-receptor recognition site.

Authors:  S V Pizzo; P A Roche; S R Feldman; S L Gonias
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

3.  Role of the scavenger receptor in the uptake of methylamine-activated alpha 2-macroglobulin by rat liver.

Authors:  M C van Dijk; W Boers; C Linthorst; T J van Berkel
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

4.  Altered interaction of Cis-dichlorodiammineplatinum(II)--modified alpha 2-macroglobulin (alpha 2M) with the low density lipoprotein receptor-related protein/alpha 2M receptor but not the alpha 2M signaling receptor.

Authors:  G C Howard; U K Misra; D L DeCamp; S V Pizzo
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

5.  Incorporation of low molecular weight molecules into alpha(2)-macroglobulin by nucleophilic exchange.

Authors:  Jennifer E Bond; George J Cianciolo; Salvatore V Pizzo
Journal:  Biochem Biophys Res Commun       Date:  2007-04-02       Impact factor: 3.575

6.  Different zonal distribution of the asialoglycoprotein receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein and the lipoprotein-remnant receptor of rat liver parenchymal cells.

Authors:  A H Voorschuur; J Kuiper; J A Neelissen; W Boers; T J Van Berkel
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

Review 7.  The LDL Receptor-Related Protein 1: At the Crossroads of Lipoprotein Metabolism and Insulin Signaling.

Authors:  Dianaly T Au; Dudley K Strickland; Selen C Muratoglu
Journal:  J Diabetes Res       Date:  2017-05-11       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.